2021
DOI: 10.1016/j.cyto.2021.155684
|View full text |Cite
|
Sign up to set email alerts
|

Unravelling the broader complexity of IL-6 involvement in health and disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 273 publications
0
17
0
Order By: Relevance
“…Increases in IL-6 and TNF-α levels in CSF and brain parenchyma are considered markers of central inflammation in depression in the context of a possible increased microglia activity and reduction of astrocyte and oligodendrocyte markers [ 38 , 39 ]. Along with evidence of monocytic, lymphocytic, and microglial activation this suggests an activated inflammatory response system in MDD [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Increases in IL-6 and TNF-α levels in CSF and brain parenchyma are considered markers of central inflammation in depression in the context of a possible increased microglia activity and reduction of astrocyte and oligodendrocyte markers [ 38 , 39 ]. Along with evidence of monocytic, lymphocytic, and microglial activation this suggests an activated inflammatory response system in MDD [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Many efforts have been made to target IL6. Most of the drugs that have been studied are monoclonal antibodies (e.g., clazakizumab, olokizumab, sirukumab, siltuximab and ziltivekimab) [ 12 ]. The possibility of targeting IL6 with small molecules has been investigated recently [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, IL‐6 antagonism changes the lipid composition to lower cholesterol‐associated proatherogenic factors, such as HDL‐associated serum amyloid‐A and secretory phospholipase‐A2 [21,22]. Similar studies also identify prominent roles for IL‐6 in pain perception, psychological well‐being, the regulation of haematopoiesis, and processes affecting tissue turnover, regeneration and repair [8,18,23–26]. How IL‐6 signalling intermediates converge to regulate these homeostatic processes while at the same time supporting host defence and the response to tissue damage is unclear.…”
mentioning
confidence: 99%
“…Similar phenotypic traits are also seen in patients with mutations in STAT1 and STAT3, the principle downstream transcription factors of IL‐6 signalling [ 9 , 16 , 17 ]. Other examples have arisen from documentation of the clinical efficacy of biological drugs and small molecule inhibitors that block the IL‐6 pathway [ 1 , 4 , 18 ]. These include monoclonal antibodies that target IL‐6 (e.g.…”
mentioning
confidence: 99%
See 1 more Smart Citation